NDC 64406-019

Byooviz

Ranibizumab-nuna

Byooviz is a Intravitreal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Biogen Inc.. The primary component is Ranibizumab.

• Product ID: 64406-019_1c0b50cf-e8c4-45ab-bbb0-4a241c25c062
• NDC: 64406-019
• Product Type: Human Prescription Drug
• Proprietary Name: Byooviz
• Generic Name: Ranibizumab-nuna
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVITREAL
• Marketing Start Date: 2022-06-01
• Marketing Category: BLA /
• Application Number: BLA761202
• Labeler Name: BIOGEN INC.
• Substance Name: RANIBIZUMAB
• Active Ingredient Strength: 10 mg/mL
• Pharm Classes: Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 64406-019-01

1 VIAL, SINGLE-DOSE in 1 CARTON (64406-019-01) > .05 mL in 1 VIAL, SINGLE-DOSE (64406-019-07)

• Marketing Start Date: 2022-06-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details